• 19 MAY 2015
    • 0

    Q&A with PharmaCyte CEO Kenneth L. Waggoner on PMCB’s New Direction

    PharmaCyte Biotech’s recently appointed CEO Kenneth L. Waggoner,  is solely focused on hitting major milestones and marks 2015 as a banner year for PharmaCyte Biotech, Inc. (OTCQB:PMCB), a Silver Spring, MD-based clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®. The

    Read more →